Middle East and Africa Non-Invasive Aesthetic Treatment Market
Published On: Jul 2021
Published On: Jul 2021
The injectables segment by procedure is estimated to lead the market growth during the forecast period.
According to a new market research study of “Middle East and Africa Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Procedure, End User and Country.” The Middle East and Africa non-invasive aesthetic treatment market is expected to reach US$ 270.52 million by 2028 from US$ 151.37 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa non-invasive aesthetic treatment market and the factors driving market along with those that act as hindrances.
The Middle East and Africa non-invasive aesthetic treatment market based on the procedure was segmented into injectables, skin rejuvenation, and others. In 2020, the injectables segment held the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years.
Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Moreover, non-invasive treatments are gaining traction due to high preference for less downtime post treatment. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people. Therefore, the growing awareness regarding non-invasive aesthetic treatment procedures is boosting the growth of the Middle East and Africa non-invasive aesthetic treatment market. Several manufacturers are working on advanced non-invasive aesthetic treatment products. In October 2020, Alma launched its latest Alma Hybrid platform, designed to explore multiple possibilities of using ablative, non-ablative, and thermal treatments, along with testing their synergistic impact, on skin rejuvenation and scar revision. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the market growth.
Socio–economic condition in Middle East countries has been widely affected by the COVID–19 pandemic. In addition, the lockdown has hindered the non-emergency medical services in the region, which has somehow adversely affected the aesthetic sectors. Saudi Arabia and the UAE are emerging as aesthetic destinations in the region. However, they are dependent on the foreign nations for the resources; therefore, the aesthetic industry has faced a negative impact and is expected to experience the same in the following few years. This is likely to have negative influence on the non-invasive aesthetic treatment market during the forecast period.
The growth of the market is attributed to a few key driving factors such as surging awareness about cosmetic procedures among consumers, availability of technologically advanced products in aesthetics, and proliferating medical tourism. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.
Galderma, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., AbbVie Inc., Candela Medical and Johnson and Johnson Services, Inc. are among the leading companies operating in the Middle East and Africa non-invasive aesthetic treatment market.
The report segments in Middle East and Africa Non-Invasive Aesthetic Treatment Market as follows:
By Procedure
By End User
By Country
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
